{"url_path":"/sec/pubc/8-k/2026-06-22/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1575858/0001493152-26-029570-index.html","accession_number":"0001493152-26-029570","cik":"0001575858","ticker":"PUBC","issuer_name":"Purebase Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1575858/0001493152-26-029570-index.html","primary_entity_key":"0001575858","primary_entity_name":"Purebase Corp"},"word_count":134,"has_tables":true,"body_markdown":"**Item\n5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain\nOfficers; Compensatory Arrangements of Certain Officers.**\n\n** **\n\nAs\npreviously reported in the Current Report on Form 8-K of Purebase Corporation (the “Company”), on June 4, 2026, Dr. Amy T.\nClemens was appointed to serve as Chief Financial Officer of the Company. On June 17, 2026, the board of directors of the Company approved\nthe payment of annual compensation of $150,000.00 to Dr. Clemens in accordance with the regular payroll practices of the Company.\n\n \n\n \n\n \n\n \n\nSIGNATURES\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \nPUREBASE\nCORPORATION\n\n \n \n \n\nDated:\nJune 22, 2026\nBy:\n\n*/s/\nA. Scott Dockter*\n\n \n \nA.\nScott Dockter\n\n \n \nChief\nExecutive Officer"}